Ten Largest Investments

Summary by AI BETAClose X

JPMorgan Claverhouse Investment Trust PLC has disclosed its ten largest investments as a percentage of total assets as of August 31, 2026. The top holding is HSBC Holdings Plc at 9.4%, followed by Shell Plc at 7.2%, and Rolls-Royce Plc at 4.8%. Other significant holdings include AstraZeneca Group Plc (4.5%), Natwest Group Plc (4.4%), Rio Tinto Plc (3.5%), British American Tobacco Plc (3.4%), Barclays Plc (3.3%), GSK Plc (3.0%), and BP Plc (2.6%). Collectively, these ten investments represent 46.0% of the Company's total assets, excluding liquidity stocks.

Disclaimer*

JPMorgan Claverhouse IT PLC
11 September 2026
 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company')

 

Legal Entity Identifier: 549300NFZYYFSCD52W53


THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 August 2026


Hsbc Holdings Plc

9.4%

Shell Plc

7.2%

Rolls-Royce Plc

4.8%

Astrazeneca Group Plc

4.5%

Natwest Group Plc

4.4%

Rio Tinto Plc

3.5%

British American Tobacco Plc

3.4%

Barclays Plc

3.3%

Gsk Plc

3.0%

Bp Plc

2.6%

Total

46.0%

Excludes Investments in Liquidity stocks


Name of contact and telephone number for queries:


Paul Ainger 0044 207 742 6524


Name of authorised company official responsible for making this notification:


Anmol Dhillon 020 7742 4000 - Company Secretary


Date: 11 September 2026

 



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings